Lux Biosciences Files For LUVENIQ™ Approval In US And Europe For Noninfectious Uveitis
Links shared publicly online about this topic.
- 1,402total visits
Lux Biosciences Files For LUVENIQ™ Approval In US And Europe For Noninfectious Uveitis
View full resource at medicalnewstoday.com
Most Recently Shared on February 8, 2010 at 8:47 am By:
Lux Biosciences Files For LUVENIQâ„¢ Approval In US And Europe For Noninfectious Uveitis http://bit.ly/9h2su8
Also Shared By:
Isotechnika's partner Lux to appeal EMA CHMP decision against Luveniq
news-medical.net — “Isotechnika Pharma Inc. today announced that its partner, Lux Biosciences, Inc. will appeal the European Medicines Agency's (EMA) decision not to approve Luveniq™ (voclosporin) as a treatment for noninfectious uveitis involving the intermediate or posterior segments of the eye.” View full resource at news-medical.net
Most Recently Shared on June 24, 2011 at 5:19 pm By:
Isotechnika's partner Lux to appeal EMA CHMP decision against Luveniq: Isotechnika Pharma Inc. today announced t... http://bit.ly/jEZHbZ
FDA Advisory Committee To Review Lux Biosciences' Uveitis Candidate Luveniq™
medicalnewstoday.com — “Lux Biosciences, Inc. today announced that the Dermatology and Ophthalmology Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is scheduled to review its New Drug Application” View full resource at medicalnewstoday.com
Most Recently Shared on May 13, 2010 at 3:12 am By:
FDA Advisory Committee To Review Lux Biosciences' Uveitis Candidate Luveniq™ http://mnt.to/3Cx6 #eyehealth
FDA Dermatology and Ophthalmology Drugs Advisory Committee to review Lux Biosciences' Luveniq NDA
news-medical.net — “Lux Biosciences, Inc. today announced that the Dermatology and Ophthalmology Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is scheduled to review its New Drug Application (NDA) for Luveniq" (oral voclosporin) for the treatment of non-infectious uveitis involving the intermediate or posterior segments of the eye on June 28, 2010.” View full resource at news-medical.net
Most Recently Shared on May 12, 2010 at 7:10 am By:
FDA Dermatology and Ophthalmology Drugs Advisory Committee to review Lux Biosciences’ Luveniq NDA: Lux Biosciences... http://bit.ly/bFVc4x
Advertisement
medical_tweets
@medical_tweets
Lux Biosciences Files For LUVENIQâ„¢ Approval In US And Europe For Noninfectious Uveitis Lux Biosciences, Inc. today .. http://bit.ly/cOKayN
1 year ago...